Amyloid brain plaques not a sure sign of Alzheimer’s, researchers find
By
Alicia Lasek
Jan 12, 2023
A new study challenges the theory that an increase in brain amyloid protein signals Alzheimer’s disease. The findings may be especially relevant to clinicians as amyloid-targeting drugs such as Leqembi...
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
Popular TV series may help reduce stigma around Alzheimer’s
By
John Roszkowski
Sep 02, 2022
The narrative and dramatization of Alzheimer’s disease in the popular TV series “This is Us” may help reduce the stigma around dementia and promote family discussions about plans for aging, new...
Clinical briefs for Wednesday, July 13
By
Alicia Lasek (f3)
Jul 13, 2022
Brexpiprazole reduces agitation in Alzheimer’s, late-stage study finds … Seniors skipping meds due to cost, survey finds … ‘Failure to thrive’ diagnostic code for seniors is problematic and dismissive,...
Most women unaware of their Alzheimer’s risk, Cleveland Clinic survey finds
By
Alicia Lasek (f3)
Jun 30, 2022
Fully 82% of U.S. women are unaware of their relatively high odds of developing Alzheimer’s disease. And most have not addressed key risk factors with a healthcare provider.
Managing Alzheimer’s as chronic disease will require clinician, patient education, docs say
May 03, 2022
Most primary care physicians foresee a time when dementia is managed as a chronic disease, new surveys from Quest Diagnostics have found.
Most elders use sleep meds, but only half discuss use with their doctors: study
By
Amy Novotney
Nov 05, 2021
Older adults frequently use medication to treat sleep difficulties, but only about half discuss it with their physicians, study results presented at Psych Congress 2021 this week found. In fact, the majority...
Two-thirds of neurologists expect to start some patients on Aduhelm next year: survey
By
Alicia Lasek
Sep 17, 2021
The outlook for the Alzheimer’s drug aducanumab (Aduhelm) is looking up, investigators say. There are small increases in the number of Aduhelm prescribers, and an uptick in patients for whom the...
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
COVID-19 connected to dementia-like disability, multiple studies find
By
Alicia Lasek
Jul 27, 2021
A bout with COVID-19 can cause dementia-like brain changes and related functional decline, especially for seniors and in people who lose their sense of smell, researchers are finding.